Dr. Keith Bellizzi is trained in gerontology, behavioral medicine, and public health. He has spent the last two decades studying resilience, cancer survivorship, healthy aging, and behavioral change. Prior to joining UConn in 2008, he was a Program Officer and Health Scientist in the Division of Cancer Control and Population Sciences at the National Cancer Institute (NCI) and graduate of the preeminent Cancer Prevention Fellowship Program at the NCI.
Motivated by his own personal experience with cancer, Dr. Bellizzi has dedicated his life to improving the lives of individuals with cancer and their families. His current research focuses on 1) mechanisms and outcomes of resilience trajectories in adults with cancer, 2) using electronic health record and patient portal data to create frailty risk profiles to help clinicians make informed treatment decisions for older patients, and 3) examining social determinants of accelerated aging in a diverse population of older adults with cancer. Dr. Bellizzi is Editor of the Cancer and Aging Handbook and Senior Associate Editor of Translational Behavioral Medicine. His research has been continuously funded by the National Institutes of Health and non-profit organizations and has been featured in U.S. News and World Report, The Washington Post, The Los Angeles Times, Australian Financial Review, Psychology Today, and many other media outlets.
Outside of work, Keith spends his time with his three girls, remodeling projects in his house, writing and blogging, mentoring, traveling and making memories with friends, and exploring many of the epic mountain bike trail systems in the U.S and Canada.
Associate Professor Laura Mauldin was quoted in an article in The Atlantic titled, “Long Covid is Being Erased—Again”.
Vida Samuel was selected to the 2023 cohort at The Campaign School at Yale (

Professor Keith Bellizzi was featured in UConn Today discussing the problems with replacing human interactions with patient portals in health care settings.
Professor Rebecca Puhl was recently interviewed by The Associated Press about potential effects of new anti-obesity medications on societal weight stigma.
Congratulations to Terry Berthelot, who received a CLAS Teaching Enhancement Grant for her project to update HDFS 3530